207 related articles for article (PubMed ID: 2550546)
1. Further studies of the role of transforming growth factor-beta in human B cell function.
Kehrl JH; Taylor AS; Delsing GA; Roberts AB; Sporn MB; Fauci AS
J Immunol; 1989 Sep; 143(6):1868-74. PubMed ID: 2550546
[TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor beta is an important immunomodulatory protein for human B lymphocytes.
Kehrl JH; Roberts AB; Wakefield LM; Jakowlew S; Sporn MB; Fauci AS
J Immunol; 1986 Dec; 137(12):3855-60. PubMed ID: 2878044
[TBL] [Abstract][Full Text] [Related]
3. Effects of transforming growth factor-beta on human lymphokine-activated killer cell precursors. Autocrine inhibition of cellular proliferation and differentiation to immune killer cells.
Kasid A; Bell GI; Director EP
J Immunol; 1988 Jul; 141(2):690-8. PubMed ID: 3133414
[TBL] [Abstract][Full Text] [Related]
4. Loss of transforming growth factor beta 1 receptors and its effects on the growth of EBV-transformed human B cells.
Kumar A; Rogers T; Maizel A; Sharma S
J Immunol; 1991 Aug; 147(3):998-1006. PubMed ID: 1713611
[TBL] [Abstract][Full Text] [Related]
5. Lack of correlation between sensitivity to growth inhibition and receptor number for transforming growth factor beta in human squamous carcinoma cell lines.
Hébert CD; Birnbaum LS
Cancer Res; 1989 Jun; 49(12):3196-202. PubMed ID: 2541899
[TBL] [Abstract][Full Text] [Related]
6. Growth inhibition of a human lymphoma cell line: induction of a transforming growth factor-beta-mediated autocrine negative loop by phorbol myristate acetate.
Sing GK; Ruscetti FW; Beckwith M; Keller JR; Ellingsworth L; Urba WJ; Longo DL
Cell Growth Differ; 1990 Nov; 1(11):549-57. PubMed ID: 1965139
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor beta: potential autocrine growth inhibitor of estrogen receptor-negative human breast cancer cells.
Arteaga CL; Tandon AK; Von Hoff DD; Osborne CK
Cancer Res; 1988 Jul; 48(14):3898-904. PubMed ID: 3164252
[TBL] [Abstract][Full Text] [Related]
8. Platelet factor 4 selectively inhibits binding of TGF-beta 1 to the type I TGF-beta 1 receptor.
Whitson RH; Wong WL; Itakura K
J Cell Biochem; 1991 Sep; 47(1):31-42. PubMed ID: 1658013
[TBL] [Abstract][Full Text] [Related]
9. Growth stimulation of human breast cancer cells with anti-transforming growth factor beta antibodies: evidence for negative autocrine regulation by transforming growth factor beta.
Arteaga CL; Coffey RJ; Dugger TC; McCutchen CM; Moses HL; Lyons RM
Cell Growth Differ; 1990 Aug; 1(8):367-74. PubMed ID: 2177634
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor-beta suppresses human B lymphocyte Ig production by inhibiting synthesis and the switch from the membrane form to the secreted form of Ig mRNA.
Kehrl JH; Thevenin C; Rieckmann P; Fauci AS
J Immunol; 1991 Jun; 146(11):4016-23. PubMed ID: 1903417
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor-beta 1 is required for secretion of IgG of all subclasses by LPS-activated murine B cells in vitro.
Snapper CM; Waegell W; Beernink H; Dasch JR
J Immunol; 1993 Nov; 151(9):4625-36. PubMed ID: 8409423
[TBL] [Abstract][Full Text] [Related]
12. IL-6 and tumor necrosis factor-alpha. Autocrine and paracrine cytokines involved in B cell function.
Rieckmann P; D'Alessandro F; Nordan RP; Fauci AS; Kehrl JH
J Immunol; 1991 May; 146(10):3462-8. PubMed ID: 2026875
[TBL] [Abstract][Full Text] [Related]
13. Effect of transforming growth factor (TGF)-beta 1 on IgA isotype expression. TGF-beta 1 induces a small increase in sIgA+ B cells regardless of the method of B cell activation.
Ehrhardt RO; Strober W; Harriman GR
J Immunol; 1992 Jun; 148(12):3830-6. PubMed ID: 1602131
[TBL] [Abstract][Full Text] [Related]
14. The Ba fragment of complement factor B inhibits human B lymphocyte proliferation.
Ambrus JL; Peters MG; Fauci AS; Brown EJ
J Immunol; 1990 Mar; 144(5):1549-53. PubMed ID: 2307833
[TBL] [Abstract][Full Text] [Related]
15. Subtypes of betaglycan and of type I and type II transforming growth factor-beta (TGF-beta) receptors with different affinities for TGF-beta 1 and TGF-beta 2 are exhibited by human placental trophoblast cells.
Mitchell EJ; Fitz-Gibbon L; O'Connor-McCourt MD
J Cell Physiol; 1992 Feb; 150(2):334-43. PubMed ID: 1310325
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibodies recognizing transforming growth factor-beta. Bioactivity neutralization and transforming growth factor beta 2 affinity purification.
Dasch JR; Pace DR; Waegell W; Inenaga D; Ellingsworth L
J Immunol; 1989 Mar; 142(5):1536-41. PubMed ID: 2537357
[TBL] [Abstract][Full Text] [Related]
17. Characterization of a 60-kDa cell surface-associated transforming growth factor-beta binding protein that can interfere with transforming growth factor-beta receptor binding.
Piek E; Franzén P; Heldin CH; ten Dijke P
J Cell Physiol; 1997 Dec; 173(3):447-59. PubMed ID: 9369958
[TBL] [Abstract][Full Text] [Related]
18. Signaling through CD19, Fc receptors or transforming growth factor-beta: each inhibits the activation of resting human B cells differently.
Barrett TB; Shu GL; Draves KE; Pezzutto A; Clark EA
Eur J Immunol; 1990 May; 20(5):1053-9. PubMed ID: 1694130
[TBL] [Abstract][Full Text] [Related]
19. Novel action of transforming growth factor beta 1 in functioning human pancreatic carcinoid cells.
Ishizuka J; Beauchamp RD; Sato K; Townsend CM; Thompson JC
J Cell Physiol; 1993 Jul; 156(1):112-8. PubMed ID: 8391003
[TBL] [Abstract][Full Text] [Related]
20. Immunodetection and modulation of cellular growth with antibodies against native transforming growth factor-beta 1.
Keski-Oja J; Lyons RM; Moses HL
Cancer Res; 1987 Dec; 47(24 Pt 1):6451-8. PubMed ID: 2890433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
